Cardiol Therapeutics Inc. (TSX: CRDL) has entered into a supplier agreement with Medical Cannabis by Shoppers, which is a subsidiary of Shoppers Drug Inc.
As per the supply agreement, CardiolRX, Cardiol’s brand of CBD products, will be exclusively sold at Shopper stores. The cannabidiol products are manufactured by Dalton Pharma Services, which will now be supplying those products to Shoppers across Canadian territories and provinces via Shopper’s online store. The cannabidiol products will be available to consumers in varying formats, of which include 25mg/mL, 50mg/mL and 100mg/mL, but are manufactured in accordance with cGMP and are free of THC. Also as part of the agreement, Shoppers has been granted the right to resell any of Cardiol’s future products.
This supply agreement comes in light of the increasing demand for a THC-free cannabidiol product which can safely be used by pediatricians on young individuals under the age of 25. In addition, THC-free cannabidiols are also ideal for elderly patients, as they do not create negative side-effects from drug interactions compared to products that do contain THC.
Cardiol Therapeutics Inc is a Canadian cannabis company focused on the development of cannabidiol products for the pharmaceutical industry. Some of the products that Cardiol develops are used as therapies for heart disease and heart failure.
Cardiol Therapeutics Inc is currently trading at $2.15 on the TSX.
Information for this briefing was found via Sedar and Cardiol Therapeutics Inc. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.
